OrthoPediatrics Corp. (NASDAQ:KIDS) CFO Fred Hite Sells 6,443 Shares

OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) CFO Fred Hite sold 6,443 shares of the company's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $160,172.98. Following the completion of the sale, the chief financial officer now directly owns 207,989 shares in the company, valued at approximately $5,170,606.54. The trade was a 3.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

OrthoPediatrics Price Performance

NASDAQ KIDS traded down $0.57 on Friday, hitting $24.97. 299,893 shares of the company were exchanged, compared to its average volume of 162,897. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19. OrthoPediatrics Corp. has a 1-year low of $21.02 and a 1-year high of $35.99. The company has a market cap of $606.45 million, a P/E ratio of -20.30 and a beta of 1.22. The firm has a 50 day moving average of $24.85 and a two-hundred day moving average of $25.48.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last released its earnings results on Tuesday, March 4th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The company had revenue of $52.67 million for the quarter, compared to the consensus estimate of $51.16 million. During the same period in the prior year, the company posted ($0.23) EPS. On average, equities analysts predict that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

Remove Ads

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Wellington Management Group LLP lifted its position in OrthoPediatrics by 16.2% during the 3rd quarter. Wellington Management Group LLP now owns 883,221 shares of the company's stock valued at $23,944,000 after purchasing an additional 122,846 shares during the period. Barclays PLC increased its stake in shares of OrthoPediatrics by 319.3% in the 3rd quarter. Barclays PLC now owns 25,298 shares of the company's stock valued at $686,000 after acquiring an additional 19,264 shares during the last quarter. Geode Capital Management LLC boosted its stake in OrthoPediatrics by 2.1% during the 3rd quarter. Geode Capital Management LLC now owns 391,492 shares of the company's stock worth $10,615,000 after acquiring an additional 7,972 shares during the last quarter. Mutual of America Capital Management LLC boosted its stake in OrthoPediatrics by 195.1% during the 3rd quarter. Mutual of America Capital Management LLC now owns 107,609 shares of the company's stock worth $2,917,000 after acquiring an additional 71,146 shares during the last quarter. Finally, Centiva Capital LP bought a new position in OrthoPediatrics during the 3rd quarter worth approximately $319,000. 69.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on KIDS shares. Needham & Company LLC reaffirmed a "buy" rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Wednesday, March 5th. Stifel Nicolaus reduced their price target on shares of OrthoPediatrics from $40.00 to $32.00 and set a "buy" rating on the stock in a research report on Wednesday, March 5th. Finally, Truist Financial reduced their price target on shares of OrthoPediatrics from $28.00 to $25.00 and set a "hold" rating on the stock in a research report on Wednesday, December 18th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.